RPMI 1640 Medium w/L-Glutamine, HEPES, w/o Leucine

RPMI-1640 was developed by Moore et. al. at Roswell Park Memorial Institute, hence the acronym RPMI. The formulation is based on the RPMI-1630 series of media utilizing a bicarbonate buffering system and alterations in the amounts of amino acids and vitamins. RPMI-1640 medium has been used for the culture of human normal and neoplastic leukocytes. RPMI-1640, when properly supplemented, has demonstrated wide applicability for supporting growth of many types of cultured cells, including fresh human lymphocytes in the 72 hour PHA stimulation assay. Appearance: Pale yellow to orange, homogeneous, free flowing powder, Solubility: Orange, clear, complete , pH: , As reported, Endotoxin: <1EU/ml, , Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.